153P Neoadjuvant therapy with tislelizumab plus chemotherapy followed by concurrent chemoradiotherapy in patients with stage IVa nasopharyngeal carcinoma: A single-arm, phase II trial. (December 2022) - Zhang, Q.; Lai, M.; Li, F.; Chen, J.; Chen, G.